Shambhu Aryal

ORCID: 0000-0002-3753-4378
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Transplantation: Methods and Outcomes
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Renal Transplantation Outcomes and Treatments
  • Pulmonary Hypertension Research and Treatments
  • Polyomavirus and related diseases
  • Organ Transplantation Techniques and Outcomes
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Sarcoidosis and Beryllium Toxicity Research
  • Medical Imaging and Pathology Studies
  • Respiratory Support and Mechanisms
  • Systemic Sclerosis and Related Diseases
  • Mechanical Circulatory Support Devices
  • Intensive Care Unit Cognitive Disorders
  • Asthma and respiratory diseases
  • Organ and Tissue Transplantation Research
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Cardiac Structural Anomalies and Repair
  • Trauma Management and Diagnosis
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Cystic Fibrosis Research Advances
  • Pleural and Pulmonary Diseases
  • Occupational and environmental lung diseases

Inova Fairfax Hospital
2018-2025

Inova Health System
2021-2024

Digital Research Alliance of Canada
2024

The Ocean Cleanup
2021

Inova Design Solutions (United Kingdom)
2020

Duke University
2014-2017

University of Kentucky
2011-2013

Purpose The outcomes of patients requiring invasive mechanical ventilation for COVID-19 remain poorly defined. We sought to determine clinical characteristics and with managed in an appropriately resourced US health care system. Methods Outcomes infected treated within the Inova Health System between March 5, 2020 April 26, were evaluated through electronic medical record review. Results 1023 positive admitted during study period. Of these, 164 (16.0%) ventilation. All followed definitive...

10.1371/journal.pone.0242651 article EN cc-by PLoS ONE 2020-11-23
Fernando J. Martínez Eric Yow Kevin R. Flaherty Laurie D. Snyder Michael T. Durheim and 95 more Stephen R. Wisniewski Frank C. Sciurba Ganesh Raghu Maria M. Brooks Dong‐Yun Kim Daniel F. Dilling Gerard J. Criner Hyun Kim Elizabeth A. Belloli Anoop M. Nambiar Mary Beth Scholand Kevin J. Anstrom Imre Noth Rebecca Bascom Scott Beegle Nitin Bhatt Sangeeta Bhorade Sachin Chaudhary Daniel A. Culver Rick Enelow Leo C. Ginns Nishant Gupta Amy Hajari Case Michael R. Hamblin Gary M. Hunninghake Robert J. Kaner Christopher S. King Michelle Kopfinger Matthew Kottmann Lisa Lancaster David J. Lederer Tracy Luckhardt Aditi Mathur Teng Moua Justin M. Oldham Rishi Raj Shelley L. Schmidt Mary E. Strek Varsha Taskar Rade Tomic Ayodeji Adegunsoye Kareem Ahmad Rifat Ahmed Timothy Albertson Martha Alemayehu Theresa Altherr Maura Alvarez Sergio Alvarez-Mulett Michaela R. Anderson Boleyn R. Andrist Adeeb Ansari Abbas Arastu Shambhu Aryal Deelan Ayhan Ken Baker Misbah Baqir Edwinia Battle Stacy Beasley B. Bemiss Joanna Beros Maneesh Bhargava Jason Biehl Reba Blissell Valerie Bloss Luigi Boccardi Melissa Boerman A.M. Bowser Kelsey Brait Linda Briggs Jenna Brinker Anne Brown Cameron Brown Cathy A. Brown Sean J. Callahan Jennifer Cannestra Brenna Cannon María G. Castro Ankit Choudhury Sarah Chu Chelsea Chung Karen Clark Michelle Clark Michele Cohen Bridget F. Collins Ashley Collins Molly Cope Josefina Corral Rebecca Cote A. G. O. Crowther Danielle Dacosta Shannon Daley Vijaya Dandamudi Priscilla Dauphin Lianne De La Cruz Mandi DeGrote

<h3>Importance</h3> Alteration in lung microbes is associated with disease progression idiopathic pulmonary fibrosis. <h3>Objective</h3> To assess the effect of antimicrobial therapy on clinical outcomes. <h3>Design, Setting, and Participants</h3> Pragmatic, randomized, unblinded trial conducted across 35 US sites. A total 513 patients older than 40 years were randomized from August 2017 to June 2019 (final follow-up was January 2020). <h3>Interventions</h3> Patients a 1:1 allocation ratio...

10.1001/jama.2021.4956 article EN JAMA 2021-05-11

Rationale: The association of acute cellular rejection (ACR) with chronic lung allograft dysfunction (CLAD) in transplant recipients has primarily been described before consensus recommendations incorporating restrictive phenotypes. Furthermore, the degree molecular injury during ACR CLAD or death remains undefined. Objectives: To investigate risk and to further if this depends on injury. Methods: This multicenter, prospective cohort study included 188 recipients. Subjects underwent serial...

10.1164/rccm.202305-0798oc article EN American Journal of Respiratory and Critical Care Medicine 2024-01-08

Abstract Background Coronavirus disease 2019 (COVID-19) requiring hospitalization is characterized by robust antibody production, dysregulated immune response, and immunothrombosis. Fostamatinib a novel spleen tyrosine kinase inhibitor that we hypothesize will ameliorate Fc activation attenuate harmful effects of the anti-COVID-19 response. Methods We conducted double-blind, randomized, placebo-controlled trial in hospitalized adults oxygen with COVID-19 where patients receiving standard...

10.1093/cid/ciab732 article EN public-domain Clinical Infectious Diseases 2021-08-28

Abstract Background Cytomegalovirus (CMV) infection is common in thoracic organ transplant recipients. Valganciclovir and ganciclovir are used for both prophylaxis treatment of this infection, but intolerance failure common. Letermovir has been demonstrated to reduce the risk CMV when allogeneic hematopoietic cell transplantation. However, there no data on its efficacy Methods We examined use letermovir either (primary secondary) or heart lung recipients at our institution from February 1,...

10.1111/tid.13166 article EN Transplant Infectious Disease 2019-09-05

Respiratory viral infection (RVI) in lung transplant recipients (LTRs) is a risk for chronic allograft dysfunction (CLAD). We hypothesize that donor-derived cell-free DNA (%ddcfDNA), at the time of RVI predicts CLAD progression. followed 39 LTRs with enrolled Genomic Research Alliance Transplantation 1 year. Plasma %ddcfDNA was measured by shotgun sequencing, high as ≥1% within 7 days RVI. examined %ddcfDNA, spirometry, and composite (progression/failure) stage progression, re-transplant,...

10.1111/ajt.17125 article EN cc-by-nc-nd American Journal of Transplantation 2022-06-22

Pulmonary hypertension (PH) commonly complicates idiopathic pulmonary fibrosis (IPF). However, the rate of change in hemodynamics IPF remains poorly defined. To examine among patients with IPF. The mean artery pressure (mPAP) and vascular resistance (PVR) was examined listed for lung transplantation. 5th 7th World Symposium on Hypertension definitions precapillary PH were employed this analysis. There 496 that had at least two right heart catheterizations (RHCs) while median time between...

10.1164/rccm.202411-2157oc article EN PubMed 2025-02-10

The Distance-Oxygen-Gender-Age-Physiology (DO-GAP) index has been shown to improve prognostication in idiopathic pulmonary fibrosis (IPF) compared the Gender-Age-Physiology (GAP) score. We sought externally validate DO-GAP GAP for baseline risk assessment patients with IPF. Additionally, we evaluated utility of serial change predicting survival.We performed an analysis IPF from Pulmonary Fibrosis Foundation-Patient Registry (PFF-PR). Discrimination and calibration two models were assessed...

10.1183/23120541.00124-2023 article EN cc-by-nc ERJ Open Research 2023-05-01

Rationale: Little is known about hospitalization in other types of interstitial lung disease (ILD) besides idiopathic pulmonary fibrosis (IPF). Objectives: We sought to determine the frequency hospitalizations various ILD and elucidate association with outcomes. Methods: An analysis Pulmonary Fibrosis Foundation Patient Registry data was performed. Inpatient rates survival following were compared for ILD. Results: Hospitalization similar across (40.6% IPF participants, 42.8% connective...

10.1164/rccm.202309-1708oc article EN American Journal of Respiratory and Critical Care Medicine 2024-01-18

Background. A prior single-center, retrospective cohort study identified baseline lung allograft dysfunction (BLAD) as a risk factor for death in bilateral transplant recipients. In this multicenter prospective study, we test the association of BLAD with recipients, identify clinical factors BLAD, and assess its injury on molecular level. Methods. This multicenter, included 173 recipients that underwent serial pulmonary function testing plasma collection donor-derived cell-free DNA at...

10.1097/txd.0000000000001669 article EN cc-by-nc-nd Transplantation Direct 2024-06-26

Rationale: Video-assisted thoracoscopic surgery (VATS) remains the gold standard for interstitial lung disease (ILD) characterization when histology is deemed necessary. There diminishing use of VATS owing to increased reliance on high-resolution computed tomographic patterns, as well concerns regarding potential morbidity and mortality procedure.Objectives: The goal this study was evaluate safety tolerability among a broad group patients with ILD referred tertiary care center.Methods: Data...

10.1513/annalsats.202006-759oc article EN Annals of the American Thoracic Society 2020-09-24

Background and aims: Chest high-resolution computed tomography (HRCT) is the central diagnostic tool in discerning idiopathic pulmonary fibrosis (IPF) from other interstitial lung disease (ILDs). In 2018, new guidelines were published nomenclature for HRCT interpretation was changed. We sought to evaluate how clinicians’ would change based on reading HRCTs under framework of old versus categorization. Materials methods: collated 50 random cases evaluated Inova Fairfax ILD clinic. Six experts...

10.1177/1753466620968496 article EN cc-by-nc Therapeutic Advances in Respiratory Disease 2020-01-01
Coming Soon ...